<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="onco13306-tbl-0002" xml:lang="en" orientation="portrait" position="float">
 <label>Table 2</label>
 <caption>
  <p>European Society for Blood and Marrow Transplantation recommendations on SARS‐CoV‐2 diagnosis</p>
 </caption>
 <table frame="hsides" rules="groups">
  <col align="left" span="1"/>
  <thead valign="bottom">
   <tr style="border-bottom:solid 1px #000000">
    <th align="left" valign="bottom" rowspan="1" colspan="1">EBMT recommendations</th>
   </tr>
  </thead>
  <tbody valign="top">
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Recipient:
     <list list-type="simple" id="onco13306-list-0005">
      <list-item id="onco13306-li-0011">
       <p>• COVID‐19 diagnosis:
        <list list-type="simple" id="onco13306-list-0006">
         <list-item id="onco13306-li-0012">
          <p>○ High risk underlying disease: HCT should be deferred until the patient is asymptomatic and has three repeated virus PCR negativity at least one week apart.</p>
         </list-item>
         <list-item id="onco13306-li-0013">
          <p>○ Low risk disease: a three‐month HCT deferral is recommended</p>
         </list-item>
        </list>
       </p>
      </list-item>
      <list-item id="onco13306-li-0014">
       <p>• Symptoms of respiratory tract infection:
        <list list-type="simple" id="onco13306-list-0007">
         <list-item id="onco13306-li-0015">
          <p>○ Testing for respiratory virus by multiplex PCR and depending on which virus is detected, deferral of HCT should be considered.</p>
         </list-item>
        </list>
       </p>
      </list-item>
      <list-item id="onco13306-li-0016">
       <p>• Close contact with a person diagnosed with COVID‐19
        <list list-type="simple" id="onco13306-list-0008">
         <list-item id="onco13306-li-0017">
          <p>○ Any transplant procedure shall be deferred for at least 14 and preferably 21 days from the last contact</p>
         </list-item>
         <list-item id="onco13306-li-0018">
          <p>○ Close monitoring for the presence of COVID‐19 by PCR</p>
         </list-item>
        </list>
       </p>
      </list-item>
      <list-item id="onco13306-li-0019">
       <p>• All HCT recipients should refrain from unnecessary travel to areas designated as high‐risk
        <xref ref-type="fn" rid="onco13306-note-0004">a</xref> by WHO
       </p>
      </list-item>
     </list>
    </td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot id="onco13306-ntgp-0003">
  <fn id="onco13306-note-0004">
   <label>a</label>
   <p>As defined by health authorities.</p>
  </fn>
  <fn id="onco13306-note-0005">
   <p>Adapted from 
    <xref rid="onco13306-bib-0019" ref-type="ref">19</xref> with permission from The European Society for Blood and Marrow Transplantation.
   </p>
  </fn>
 </table-wrap-foot>
</table-wrap>
